Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 8/20 | 0.63 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.46 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9452155 | 1.00 | PRKCA (0.63) | PRKCAPRKCEPRKCQPRKCDBLM | |
| SCHEMBL11896012 | 1.00 | PRKCA (0.63) | PRKCAPRKCEPRKCQPRKCDBLM | |
| SCHEMBL30557897 | 0.91 | PRKCA (0.47) | PRKCAPRKCEPRKCQPRKCDBLM | |
| SCHEMBL21686371 | 0.90 | PRKCA (0.50) | PRKCAPRKCEPRKCQPRKCDBLM | |
| SCHEMBL234142 | 0.82 | ENPP2 (0.51) | PRKCA | |
| SCHEMBL23706432 | 0.82 | LMNA (0.46) | PRKCABLM | |
| SCHEMBL1521671 | 0.81 | PRKCA (0.42) | PRKCABLM | |
| SCHEMBL26236288 | 0.81 | SELP (0.49) | PRKCA | |
| SCHEMBL14415223 | 0.81 | PRKCA (0.74) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL3574597 | 0.81 | BLM (0.41) | PRKCABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026098635-A1 | NEW CATIONIC LIPID WITH NITROGEN-CONTAINING HETEROCYCLIC HEAD GROUP AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2026-05-15 | — | — | WO | claimed |
| CN-118697900-A | Method for preparing lipid nanoparticles | 摩登纳特斯有限公司 | 2024-09-27 | — | — | CN | claimed |
| WO-2024067816-A1 | PEGYLATED LIPID CONTAINING LYSINE CORE | 厦门赛诺邦格生物科技股份有限公司 | 2024-04-04 | — | — | WO | claimed |
| WO-2024051825-A1 | CARBON NUCLEUS CATIONIC LIPID | 厦门赛诺邦格生物科技股份有限公司 | 2024-03-14 | — | — | WO | claimed |
| WO-2023232148-A1 | AMINO ACID-BASED CATIONIC LIPID CONTAINING UNSATURATED BONDS | 厦门赛诺邦格生物科技股份有限公司 | 2023-12-07 | — | — | WO | claimed |
| WO-2023232147-A1 | AMINO ACID CATIONIC LIPID | 厦门赛诺邦格生物科技股份有限公司 | 2023-12-07 | — | — | WO | claimed |
| WO-2023198083-A1 | NONLINEAR PEGYLATED LIPID CONTAINING TERTIARY AMINE AND APPLICATION THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2023-10-19 | — | — | WO | claimed |
| WO-2023198085-A1 | NITROGEN-BRANCHED NONLINEAR PEGYLATED LIPID CONTAINING TERTIARY AMINE AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2023-10-19 | — | — | WO | claimed |
| WO-2023198082-A1 | NON-LINEAR PEGYLATED LIPID AND APPLICATION THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2023-10-19 | — | — | WO | claimed |
| CN-115916163-A | Novel lipids and nanoparticle compositions thereof | 世代生物公司 | 2023-04-04 | — | — | CN | claimed |
| WO-2026103877-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 中生复诺健生物科技(上海)有限公司 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026098601-A1 | LIPID NANOPARTICLE FOR DELIVERING LOAD | 北京剂泰生命科技有限公司 | 2026-05-15 | — | — | WO | disclosed |
| EP-3682023-B1 | TUNING AND CALIBRATION FEATURES OF A SEQUENCE-DETECTION SYSTEM | ILLUMINA INC (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-3682020-B1 | SEQUENCE-DETECTION SYSTEM | ILLUMINA INC (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20250224411-A1 | MOLECULAR HOPPER | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2025-07-10 | — | — | US | disclosed |
| US-11352647-B2 | Crispr enzymes and systems | THE BROAD INSTITUTE, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| CN-111225744-B | Protein nanopores removal and reinsertion into membranes using osmotic imbalance | 豪夫迈·罗氏有限公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-216337555-U | Pore array layer structure, chip device and nanopore sequencing device | 成都齐碳科技有限公司 | 2022-04-19 | — | — | CN | disclosed |
| EP-2410990-A1 | COMPOSITIONS AND METHODS FOR ENHANCING CONTRAST IN IMAGING | Marval Biosciences, Inc. (US) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010107990-A1 | COMPOSITIONS AND METHODS FOR ENHANCING CONTRAST IN IMAGING | MARVAL BIOSCIENCES, INC. (US) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352647-B2 | Crispr enzymes and systems | CPSF1, CPN1, CPSF6 | PRKCA 2526/4885PRKCE 2388/4885PRKCQ 2498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.